Luyan Pharma Co (SZSE:002788) Accounts Payable & Accrued Expense : ¥3,780 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co Accounts Payable & Accrued Expense?

Luyan Pharma Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥3,040 Mil) to Dec. 2023 (¥3,814 Mil) but then declined from Dec. 2023 (¥3,814 Mil) to Mar. 2024 (¥3,780 Mil).

Luyan Pharma Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥2,795 Mil) to Dec. 2022 (¥3,729 Mil) and increased from Dec. 2022 (¥3,729 Mil) to Dec. 2023 (¥3,814 Mil).

Luyan Pharma Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Luyan Pharma Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co Accounts Payable & Accrued Expense Chart

Luyan Pharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2,332.29

2,501.67

2,794.96

3,729.43

3,813.55

Luyan Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3,112.09	3,152.81	3,039.95	3,813.55	3,779.89

Luyan Pharma Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Luyan Pharma Co (SZSE:002788) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010

Website

http://www.luyan.com.cn

Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.

Executives

Zhu Ming Guo	Executives
Yang Cong Jin	Directors, executives
Lei Ming	Directors, executives
Li Wei Yang	Executives
Cai Mei Zhen	Supervisors
Li Cui Ping	Supervisors
Wu Jin Xiang	Directors, executives
Zhang Jun Ying	Executives
Wu Huo Lu	Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines